Recent Articles

• 
  Bioprocessing / CDMO

  “Hamster Cells Too Costly”: Cancer Drug Made From Eggs

  As more than 70% of protein pharmaceuticals, including immune-oncology drugs, depend on Chinese hamster ovary cells, some scientists are drawing attention by studying eggs as a low-cost alternative candidate. Photo credit: Wikimedia The majority of the world’s best-selling medicines, including the r

  2026.05.08
• 
  Pharmaceutical R&D

  SK Biopharm Posts Record Q1 Profit, Speeds TPD Investment

  SK Biopharmaceuticals research center. Provided by SK Biopharmaceuticals SK Biopharmaceuticals achieved its highest-ever quarterly performance in the first quarter of 2026. With robust growth of its epilepsy treatment cenobamate driving earnings, the company is assessed to be fully activating its “B

  2026.05.07
• 
  Biopharma

  Obesity Drug Mounjaro Becomes Top-Selling Medicine Worldwide

  A pharmacist in a U.S. pharmacy holds Eli Lilly’s obesity and diabetes treatment “Mounjaro.” Mounjaro ranked as the world’s top-selling pharmaceutical product in the first quarter of 2026. Getty Images Eli Lilly & Co.’s obesity and diabetes treatment “Mounjaro” has overtaken Merck & Co.’s cancer dru

  2026.05.07
• 
  Diagnostics / Monitoring

  Accurately Predicting Response Before Immunotherapy

  A domestic research team has developed a personalized diagnostic technology that can precisely analyze even minute differences within tumors at the single-cell level and accurately predict therapeutic responses to immuno-oncology drugs.On the 6th, Gwangju Institute of Science and Technology (GIST) a

  2026.05.07
• 
  Global Business

  GC Cell Wins Japan Cell Therapy Manufacturing Nod

  GC Cell (GC Cell) announced on the 6th that it has obtained final certification for its Cell Processing Center (CPC) for the manufacture of specified cell products from Japan’s Ministry of Health, Labour and Welfare (MHLW). This certification was officially granted following an on-site inspection by

  2026.05.06
• 
  Celltrion

  Celltrion Q1 Operating Profit Jumps 115%, Record High

  Panoramic view of Celltrion headquarters. Provided by Celltrion Celltrion continued its earnings growth momentum by posting record-high first-quarter results this year.Celltrion announced on the 6th, via a regulatory filing, that on a consolidated basis for the first quarter of 2026 it recorded reve

  2026.05.06
• 
  Pharmaceutical R&D

  Hanmi Pharma Q1 Profit Falls 9% on R&D Spend

  Headquarters of Hanmi Pharmaceutical. Courtesy of Hanmi Pharmaceutical Hanmi Pharmaceutical announced on the 30th that it recorded sales of KRW 392.9 billion and operating profit of KRW 53.6 billion in the first quarter of this year. Compared with the first quarter of last year, sales increased by 0

  2026.04.30
• 
  Medical / Research

  Why Eat When Sick? Immune Cell Activity Surges

  Photo=Getty Images Bank. There is a saying that the more one is ill, the better one should eat to recover. Scientific evidence has now been presented to support this claim.In experiments on humans and mice, a specific type of immune cell known as T cells showed enhanced activation capacity after foo

  2026.04.30
• 
  Medical / Research

  Discarded Tangerine Peels Help Heal Irradiated Organs

  It has been confirmed that hesperidin, a component found in tangerine peels, helps restore liver, heart, and kidney tissues damaged by radiation. Getty Images Bank It has been confirmed that hesperidin, a component derived from tangerine peels, helps restore liver, heart, and kidney tissues damaged

  2026.04.30
• 
  Biopharma

  HanAll BioPharma Turns Q1 Operating Profit Positive

  HanAll Biopharma turned to an operating profit in the first quarter, driven by growth in its pharmaceuticals business.HanAll Biopharma announced on the 29th that on a consolidated basis it posted sales of KRW 40 billion in the first quarter of 2026, an increase of 11% year-on-year. Operating profit

  2026.04.29